News related to
risk

The Orchard Road clinic outlines a goal-based alternative to off-the-shelf test packages*

SINGAPORE – Media OutReach Newswire – 22 October 2026 – Hisential Clinics Singapore, a doctor-led health screening and men’s health clinic at Mandarin Gallery, Orchard Road, has outlined its goal-based approach to men’s preventive health ahead of Movember 2026. As consumer platforms market standardised blood test panels directly to the public, the clinic is highlighting the role of doctor-led risk stratification, physical examination and long-term follow-up in effective health screening. Group Medical Director Dr Julian Ng is available for interviews during November to discuss the approach.

Each November, Movember campaigns encourage men to see a doctor. Health outcomes for men, however, have been slow to improve, according to the clinic. The clinic attributes this gap partly to preventive health having followed a consumerist route. Digital wellness platforms now sell blood tests the way meal-kit apps sell dinners: a panel is selected, purchased and delivered. Screening is packaged like phone plans, tiered and compared by item counts. The underlying assumption is that a health check is a product.

“The first question we ask is not which package are you here for. It is what is the goal,” Dr Ng said. “A thirty-five-year-old with a family history of heart disease and a fit fifty-year-old with none do not need the same tests. They need the same conversation. Everything that follows, what we test, what we watch, when we see you again, is built backwards from that answer.”

The clinical case against off-the-shelf testing is straightforward: medicine is not just blood tests. A number on a report means different things in different bodies. The same cholesterol reading can be reassuring for one man and a warning for another, depending on his age, family history, blood pressure, and what a doctor finds on examination.

This is risk stratification, and it is why the physical examination still matters in an age of app-ordered panels. A murmur heard through a stethoscope, a detail no mail-order test captures, can change how a doctor interprets a cholesterol reading and what target is appropriate for that patient. Without the examination and the history, screening becomes numbers without medical context.

“Men come to us carrying printouts from testing platforms, sometimes anxious over a value that means very little for them, sometimes reassured by one that should have prompted more questions,” Dr Ng said. “A blood test is a tool, not a diagnosis. It only becomes medicine when somebody takes the time to place it in the context of the person standing in front of them.”

The men who avoid screening appointments are often disciplined in other areas of life, the clinic has observed. What they avoid is being processed: selecting a package from a menu and leaving with numbers nobody explained.

Hisential’s answer is a different kind of appointment. At the Mandarin Gallery clinic, a consultation is built around two things: the goal, and the time to reach it. Time with the practitioner matters twice over. The first question a man asks is usually the safe one he rehearsed, often about cholesterol. The question that actually brought him in surfaces once he trusts the doctor and sees there is time for the answer. Most health systems never hear the second question.

The consultation also builds structure for what follows. Doctor and patient agree on what is being monitored, the patient’s baseline, and what happens at the next check. Patients who leave with that structure keep the habit, the clinic finds. Prevention, in this model, is a series of future decisions set up in advance.

The approach speaks to a wider conversation in Singapore about healthspan, healthy years rather than simply years. Healthspan is not bought in a single transaction, according to the clinic. It is built through understanding one’s health numbers, what they mean in context, and catching quiet changes early, when the response can still be small. That requires a practitioner who knows a patient’s goals and history, not a panel that knows neither.

“The men who do best in preventive health are not the ones who bought the biggest test package on day one,” Dr Ng said. “They are the ones who left with their questions answered, a goal defined, and a reason to return. Everything after that is easy.”

The clinic’s view is that men’s health services more broadly would benefit from the same shift: fewer standardised packages, more appointments and relationships worth keeping.

Hisential Clinics Singapore provides doctor-led health screening and men’s health services at Mandarin Gallery, 333A Orchard Road. Interviews with Dr Julian Ng, Group Medical Director, can be arranged on request.
Hashtag: #MensHealth #HealthScreening #Movember

https://hisential.sg
https://www.linkedin.com/company/hisential

The issuer is solely responsible for the content of this announcement.

Hisential Clinics Singapore

Hisential Clinics Singapore offers doctor-led health screening and men’s health services at Mandarin Gallery, Orchard Road. More information: https://hisential.sg/health-screening

The annual flagship program builds on the success of its first two editions, bringing global experts together around an agenda shaped by the green transition’s most urgent challenges and opportunities.

HONG KONG SAR – Media OutReach Newswire – 21 October 2026 – GoImpact will convene the 3rd Green Tech Summit on October 21-22 at Fullerton Ocean Park Hotel, Hong Kong, bringing together over 50 world-class experts and leaders from across sectors to exchange ideas and showcase solutions under the theme of “turning climate risks into opportunities”.

Now in its third year, the Summit builds on the success of its first two editions and its role as a signature annual convening for cross-sector expertise. This year’s agenda is designed to move beyond discussion—creating space for participants to examine shared challenges, connect perspectives and identify opportunities for meaningful progress. With continuous strong support from Corporate Partners like HSBC, Swiss Reinsurance, Stephenson Harwood, and Sino Group, with City University of Hong Kong as Academic Partner, US Green Building Council as Learning Partner, and many trade associations as Community Partners, the Summit is a focal point gathering over 400 participants.

“To achieve a green and sustainable future, we need green capital at an unprecedented scale. Hong Kong will continue to leverage our robust financial structures and technological innovation to connect green projects with international capital, and work with our partners to build a greener future.,” said Joseph Chan, Under Secretary of Financial Services and Treasury Bureau of the HKSAR Government who is the guest-of-honour opening the Summit.

“The intersection of Green and Tech continues to be the important nexus driving actions and results in a world that faces increasingly harsh consequences of climate change-related risks,” “The Summit is a collective call to action for us to come together and focus on such priorities,” said Helene Li, CEO & Co-Founder of GoImpact.

The programme will feature over 20 sessions and workshops, with contributions from leading players such as the Bank for International Settlements, Henderson Land Development, National University Health System of Singapore and more.. The Summit will bring different perspectives into the conversation to support practical collaboration.

Hashtag: #GoImpact #GreenTechSummit2026

The issuer is solely responsible for the content of this announcement.

About GoImpact

Bridging the great divide between the talk and action, the move from ambition to action, accelerating the Sustainable Development agenda from intention to implementation – GoImpact means impact made easy and actionable.

GoImpact is an ecosystem developed to connect the dots and provide action enablers built around 2 key pillars:

• Education
• Advocacy

Through its partners network with online-to-offline initiatives along with connections to corporate organisations, higher-education institutes and regulators, GoImpact connects investors with deals relevant to their interests and provide learning opportunities to drive real change by example for everyone who is keen to understand more about the Sustainable Finance agenda.

Initiative offers 1,000 free paediatric eye examinations, 1,000 free adult myopia screenings and a planned three-year myopia-control trial

HONG KONG SAR – Media OutReach Newswire – 20 October 2026 – As part of its mission to eliminate avoidable vision loss, Orbis and the LKS Faculty of Medicine of the University of Hong Kong (HKUMed), partnered to tackle the growing, lifelong burden of short-sightedness (myopia) across Hong Kong. The joint initiative highlights how myopia takes root early in primary school and, if left unmanaged, poses a severe, sight-threatening risk in later life.

Rather than a minor inconvenience corrected by stronger glasses, unmanaged high myopia physically alters the structure of the eye, drastically increasing the lifetime risk of irreversible blindness. Drawing on insights from HKUMed’s academic research and data from the joint Orbis x HKUMed Vision Matters community screening project, this partnership provides a crucial wake-up call on how lifelong visual health is determined during childhood.

In direct response to this public health challenge, Orbis and the Department of Ophthalmology, School of Clinical Medicine, HKUMed, are taking immediate action by offering 1,000 free comprehensive eye examinations for local children. This initiative gives families immediate access to expert care, early detection, and evidence-based guidance to safeguard their children’s sight before permanent damage occurs. In parallel, free eye screening will be provided to 1,000 adults aged over 50 years with known myopia. The 1,000 paediatric eye examinations and 1,000 adult eye screenings are all part of the HKUMed 140 for the Community Campaign.

A Lifelong Threat: From Classroom to Later Life

The joint effort establishes a clear, connected narrative across two generations:

• Myopia Starts Early: A 2025 HKUMed study conducted at the HKU Eye Centre examined 501 children aged 5–12 and found that nearly 40% suffered from myopia. These findings reinforce the urgent need for regular professional eye examinations, even when a child has not reported any vision problems.
• Consequences Last a Lifetime: To evaluate the long-term impact, HKUMed researchers analysed 4,217 adults aged 50 and older through the Orbis x HKUMed Vision Matters: Glaucoma AI-ROTA Screening Project. The analysis revealed that 44.5% of older adults suffer from myopia, with 6.7% suffering from high myopia. Given the historical lack of recent large-scale Hong Kong data based on objective eye measurements in this demographic, these findings represent an important public health update.
• Clear Vision Does Not Remove Risk: Myopia develops when the eye grows excessively long, causing distant objects to appear blurred. While glasses can correct distance vision, they do not shorten an elongated eye or eliminate the long-term risks associated with high myopia, including retinal disease, glaucoma, cataracts, and permanent sight loss.

In the adult analysis, visual impairment or blindness was roughly twice as common among individuals with myopia and more than four times (6.3% vs. 1.5%) as common among those with high myopia, compared to those without myopia. Glaucoma—the leading cause of irreversible blindness—was also nearly twice as prevalent among people with high myopia compared to those without (13.1% vs. 6.8%). Together, these findings highlight the critical importance of identifying and managing myopia early, before it progresses into high myopia.

Practical Action: Free Screenings and Clinical Solutions

To bridge medical evidence with practical community action, Orbis and the Department of Ophthalmology, School of Clinical Medicine, HKUMed are rolling out complementary initiatives. The 1,000 paediatric examinations and 1,000 adult screenings are all part of the HKUMed 140 for the Community Campaign:

• 1,000 Free Paediatric Examinations: Providing local families with comprehensive eye checks to help identify eye problems early and obtain professional advice on appropriate follow-up care and myopia management.
• Free Eye Screening for 1,000 Adults with Myopia: Providing free eye screening to 1,000 adults aged over 50 years with known myopia.
• Landmark “2027 Children Myopia Control Study”: Supporting a three-year HKUMed clinical trial to evaluate three advanced intervention strategies among children aged 5–12: 0.05% atropine eye drops, optical defocus spectacle lenses, and a combination of both therapies.

AT A GLANCE

• Children: 39.7% of 501 children aged 5–12 screened had myopia.
• Adults: 44.5% of 4,217 participants aged 50+ had myopia; 6.7% had high myopia.
• Impact: Visual impairment or blindness affected 6.3% of adults with high myopia, versus 1.5% without myopia.
• Action: 1,000 child exams; 1,000 screenings for myopic adults over 50. All are free under the HKUMed 140 for the Community Campaign.
• Next step: Three-year trial of 0.05% atropine, defocus spectacle lenses, and combined therapy.

Leadership Quotes:

Professor Chak-sing Lau, Vice-President and Pro-Vice-Chancellor (Health) and Deanof Medicine, HKU:

“Myopia is an increasingly important public health challenge that places a substantial lifelong burden on individuals and society. Through the HKUMed 140 for the Community Campaign, these initiatives reflect our longstanding commitment to translating academic excellence into meaningful benefits for the community. HKUMed is dedicated to transforming pioneering research into real-world health benefits. Through our partnership with Orbis, we seek to integrate clinical excellence, technological innovation, and population health research to lessen the impact of myopia and its complications in Hong Kong, while providing robust scientific evidence to guide eye health policy and clinical practice in the region. Together, we are working to safeguard the long-term visual health of schoolchildren and the wider population.”

Kathleen Sherwin, President and CEO of Orbis International:

“This partnership connects community service directly with research. The adult screening programme gives us a clearer view of the long-term burden of myopia, while the children’s examinations and planned trial focus on acting earlier. Together, Orbis and HKUMed are turning evidence into practical steps to protect sight.”

Mary Lau, Director of Orbis Hong Kong:

“Parents should see myopia as a condition that needs active management, not simply stronger glasses. By offering 1,000 child exams; 1,000 screenings for myopic adults over 50, we want to help more families identify problems early, obtain professional advice and take action to protect their different generation’s sight.”

Professor Christopher Leung Kai-shun, Albert Bing-Ching Young Professor in Ophthalmology, Chairperson and Clinical Professor, Department of Ophthalmology, School of Clinical Medicine, HKUMed:

“Vision Matters is showing us that myopia is an important part of the eye-health burden among Hong Kong’s over-50s. Glasses can correct blurred vision, but they cannot reverse the excessive growth of the eye or eliminate the risk of permanent sight loss associated with high myopia. The earlier we act, the greater the opportunity to protect sight over a lifetime.”

Dr Helen Zhang, Principal Investigator of the 2027 Children Myopia Control Study; and Clinical Assistant Professor, Department of Ophthalmology, School of Clinical Medicine, HKUMed

“This trial will compare eye drops, myopia-control lenses and both treatments combined. We aim to provide clearer evidence to help families choose the right approach for their children.”

Dr Kendrick Shih, Investigator of the 2027 Children Myopia Control Study; and Clinical Associate Professor of Practice, Department of Ophthalmology, School of Clinical Medicine, HKUMed:

“Myopia can worsen without obvious warning signs. Regular monitoring and timely treatment can help protect a child’s vision for the future.”

What Parents Can Do

• Prioritize Annual Checks: Arrange regular professional eye examinations rather than waiting for visual symptoms to appear.
• Explore Clinical Control Options: Seek advice from a qualified eye-care professional if myopia is detected.
• Look Beyond Standard Glasses: Discuss evidence-based myopia-control options instead of relying only on stronger prescriptions.
• Encourage Healthy Visual Habits: Encourage outdoor time, regular breaks from close work, and maintain a comfortable reading distance.

Public Registration & Participation

Registration will open in phases:
Phase 1 (Now Open): Free eye screenings for children aged 5–12 (limited quotas, first-come, first-served).
Online Registration: https://forms.cloud.microsoft/r/CzitVUBgJQ

Phase 2 (Coming Soon): Free eye screenings for myopic adults aged 50 or above. Details will be announced on the HKU portal and official Orbis channels.

Hashtag: #Orbis #HKUMed #Myopia

The issuer is solely responsible for the content of this announcement.

By Nantoo Banerjee The prolonged blockade of the Strait of Hormuz, lately due to the ego tussle between the United States and Iran, have inflicted severe financial, operational, and human costs on India’s merchant marine industry and broader import-export trade. But, thanks to an excellent supply chain management effort, it failed to impact the country’s […]

The article Excellent Supply Chain Handling Helped India Avoid A Major Stagflation appeared first on Latest India news, analysis and reports on Newspack by India Press Agency).

By Dr. Nilanjan Banik The Union Cabinet’s approval, on 14 October 2026, to sell the government’s and LIC’s combined 60.72% stake in IDBI Bank to a Fairfax Financial Holdings subsidiary for about ₹52,878 crore is more than another entry in India’s disinvestment ledger. At roughly $5.6 billion, it is the largest foreign investment yet in […]

The article IDBI Bank-Fairfax Deal Has Some Lessons For Modi Govt’s Disinvestment Strategy appeared first on Latest India news, analysis and reports on Newspack by India Press Agency).

Singh estimated the sector’s current value at approximately $9 billion and projected it could reach $40 billion to $45 billion over seven to eight years. Speaking at a New Delhi roundtable on Saturday, he said the next priority was building internationally competitive businesses rather than simply demonstrating technological capabilities.

The minister identified predictable customer demand, domestic and overseas capital, efficient approvals and sustainable business models as essential conditions for expansion. His remarks at the Bloomberg New Economy Forum placed commercial viability at the centre of the government’s efforts to enlarge the role of private companies in space activities.

Government departments could become anchor customers for emerging enterprises, Singh said, providing contracts that enable businesses to test technology and develop products for wider markets. Support for proof-of-concept projects would also help companies demonstrate practical applications before committing to larger production programmes.

Such arrangements could address a central challenge for space ventures: securing reliable revenue while facing substantial development costs and lengthy periods before projects generate returns. Singh argued that an identifiable customer base would encourage manufacturing investment and allow companies to establish more durable commercial operations.

He also called for defined timeframes for installation and export licences, alongside lower operating costs and better integration of supply chains. Regulatory improvements, he said, must produce practical results for companies seeking to enter the market or expand their activities.

Singh referred to goods and services tax measures affecting space products, saying policy changes should deliver tangible benefits to industry. He did not announce a fresh tax package or specify new deadlines for regulatory decisions during the discussion.

The forecast broadly matches the longer-term ambition set out by the Indian National Space Promotion and Authorisation Centre, or IN-SPACe, which has outlined a $44 billion space economy by 2033. Its strategy envisages $11 billion in exports, with opportunities spanning satellite communications, navigation, Earth observation, manufacturing and launch services.

That target remains an aspiration rather than an assured outcome. Delivering it would require sustained growth across multiple segments, with private operators securing customers and financing while navigating technical, regulatory and commercial risks.

Figures disclosed to Parliament in July illustrate both the expansion of private participation and the distance still to travel. Singh said cumulative private investment had reached $618.5 million by March 31, 2026, while $187 million had been reported during 2026. The government had granted 105 authorisations to non-government entities as of July 14.

Those authorisations are subject to national security and strategic considerations under IN-SPACe procedures. The government has said it is developing dedicated safety and security guidelines as commercial activity expands, reflecting the need to balance market access with oversight of sensitive technologies.

Singh said international partnerships could bring investment, technological expertise and access to overseas customers, while domestic capabilities remained important for strategic autonomy. He advocated closer cooperation among government agencies, private enterprises and foreign partners, particularly where collaboration could strengthen manufacturing networks and market access.

He pointed to satellite communications, geospatial services and Earth observation as areas where space technology already supports economic activity. Applications include infrastructure monitoring, agriculture, disaster management and defence, alongside services built around satellite data.

The minister highlighted government use of geotagging to monitor development projects, track implementation schedules and assist administrative clearances. He also cited space-based disaster information supplied to neighbouring countries, including Myanmar, Bangladesh and Sri Lanka.

The commercialisation programme follows the opening of space activities to private participation in 2019 and 2020, a change that enabled enterprises to work alongside public institutions. Singh said that cooperation had yielded results but that technical achievement alone would not guarantee commercial success. The distinction is significant for companies developing satellite hardware, data services and launch technologies: demonstrating that a system works is different from securing repeat orders at prices sufficient to sustain operations. Public procurement and export access could therefore influence investment decisions.

The roundtable, titled Space, Sovereignty and New Economy, included IN-SPACe promotion director Vinod Kumar and Aisha Bowe, founder and chief executive of STEMBoard and LINGO, a former NASA engineer who has flown with Blue Origin. Participants discussed investment, international cooperation and the challenge of converting national space capabilities into commercially viable enterprises.